Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
OmniAb
OmniAb
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
OmniAb
Stock Price
$3.9
2024-10-28
Market Capitalization
$457.3 M
2024-10-28
OmniAb Summary
Company Summary
Overview
OmniAb is a biotechnology company that specializes in antibody screening solutions. It offers a transgenic chicken host system for the production of single domain antibodies.
Type
Public
Status
Active
Founded
2012
Website
https://www.omniab.com/
Cybersecurity rating
Sectors
Healthcare
biotech
healthtech
pharma
therapy
Homepage
Linkedin
youtube
twitter
Table of Contents
Competitors
Competitors and Similar Companies
Allakos
Healthcare - Subsidiary
Edgewise Therapeutics
Healthcare - Public
Xenikos
Healthcare - Private
ALX Oncology
Healthcare - Public
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top